T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $4.57 and traded as high as $5.54. T2 Biosystems shares last traded at $5.34, with a volume of 93,023 shares traded.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group decreased their price objective on shares of T2 Biosystems from $12.00 to $3.00 and set a “hold” rating on the stock in a research report on Monday, April 29th.
Get Our Latest Stock Report on T2 Biosystems
T2 Biosystems Stock Down 1.7 %
T2 Biosystems (NASDAQ:TTOO – Get Free Report) last announced its earnings results on Monday, May 6th. The medical equipment provider reported ($2.66) earnings per share for the quarter. The company had revenue of $2.06 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently raised its position in T2 Biosystems stock. Virtu Financial LLC boosted its position in T2 Biosystems, Inc. (NASDAQ:TTOO – Free Report) by 29.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,096 shares of the medical equipment provider’s stock after purchasing an additional 3,018 shares during the quarter. Virtu Financial LLC owned about 0.24% of T2 Biosystems worth $39,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 23.18% of the company’s stock.
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Featured Articles
- Five stocks we like better than T2 Biosystems
- What is an Earnings Surprise?
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- What is the Dow Jones Industrial Average (DJIA)?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.